Comparison of Two Different Rota-Flush Solutions in Patients Undergoing Rotational Atherectomy: A Randomized, Controlled, Triple-Blind Trial.
Zhiqing GuoHao HuJinsheng HuaLikun MaPublished in: Cardiology and therapy (2022)
The findings suggest that although continuous intracoronary infusion of heparin rota-flush solution does not increase the incidence of slow flow/no-reflow, traditional rota-flush solution without RotaGlide prevents coronary spasm more effectively compared to the heparin rota-flush without significant impact on severe hypotension. These results do not support a strategy of routine use of heparin rota-flush solution in patients receiving RA procedures.
Keyphrases
- venous thromboembolism
- patients undergoing
- growth factor
- coronary artery
- coronary artery disease
- rheumatoid arthritis
- clinical trial
- study protocol
- risk factors
- phase iii
- low dose
- randomized controlled trial
- mouse model
- clinical practice
- acute coronary syndrome
- early onset
- phase ii
- disease activity
- placebo controlled
- double blind